Regeneron Pharmaceuticals, Inc.

Wilmington Savings Fund Society, FSB REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

106

Value ($000)

Weight

0.0%

2020 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	82	0.0%	106	12/31/2025
2025 Q3	11/20/2025	60	0.0%	106	9/30/2025
2025 Q2	7/28/2025	381	0.0%	726	6/30/2025
2025 Q1	5/8/2025	781	0.0%	1,231	3/31/2025
2024 Q4	1/28/2025	1,207	0.0%	1,695	12/31/2024
2024 Q3	11/25/2024	1,903	0.0%	1,810	9/30/2024
2024 Q2	8/8/2024	648	0.0%	617	6/30/2024
2024 Q1	5/15/2024	603	0.0%	627	3/31/2024
2023 Q3	11/15/2023	523	0.0%	635	9/30/2023
2023 Q2	8/11/2023	475	0.0%	661	6/30/2023
2023 Q1	5/15/2023	543	0.0%	661	3/31/2023
2022 Q4	2/13/2023	470	0.0%	652	12/31/2022
2022 Q3	11/14/2022	449	0.0%	652	9/30/2022
2022 Q2	8/11/2022	385	0.0%	652	6/30/2022
2022 Q1	5/16/2022	455	0.0%	652	3/31/2022
2021 Q4	2/10/2022	412	0.0%	652	12/31/2021
2021 Q3	10/26/2021	395	0.0%	652	9/30/2021
2021 Q2	7/29/2021	364	0.0%	652	6/30/2021
2021 Q1	4/23/2021	310	0.0%	656	3/31/2021
2020 Q4	2/11/2021	514	0.0%	1,063	12/31/2020